Evidence map›Paper›PMID 32212792›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of Lung Cancer: Findings from the Fukuoka Tobacco-Related Lung Disease (FOLD) Registry.

Masako Arimura-Omori, Chikako Kiyohara, Toyoshi Yanagihara, Yuzo Yamamoto, Saiko Ogata-Suetsugu, Eiji Harada, Naoki Hamada, Toru Tsuda, Shohei Takata, Ikuko Shimabukuro and 6 more

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Telomere length andRadiology and oncology · 2024
    Observational
  5. Observational
  6. Article
  7. Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Masako Arimura-OmoriResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Chikako KiyoharaDepartment of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University,Fukuoka,Japan.
Toyoshi YanagiharaResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuzo YamamotoResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Saiko Ogata-SuetsuguResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Eiji HaradaResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Naoki HamadaResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toru TsudaKirigaoka Tsuda Hospital, Fukuoka, Japan.
Shohei TakataDivision of Respiratory Medicine, National Hospital Organization, Fukuoka Higashi Medical Center, Fukuoka, Japan.
Ikuko ShimabukuroDivision of Respiratory Medicine, Kyushu Rosai Hospital, Fukuoka, Japan.
Nobuhiko NagataDepartment of Respiratory Medicine, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Kazuhiro YateraDepartment of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Fukuoka, Japan.
Ryo ToriiDepartment of Respiratory Medicine, Wakamatsu Hospital of the University of Occupational and Environmental Health, Japan, Fukuoka, Japan.
Masaki OkamotoDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Masaki FujitaDepartment of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
Yoichi NakanishiResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kyushu University · JPFukuoka University · JPUniversity of Occupational and Environmental Health Japan · JPFukuoka Higashi Medical Center · JPKurume University · JPKyushu Rosai Hospital · JPTsuda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer coexisting with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) can lead to poor prognosis.  Telomere-related polymorphisms may be implicated in the pathogenesis of these three lung diseases.  As to elucidate the mechanism of lung cancer via IPF or COPD may enable early detection and early treatment of the disease, we firstly examined the association between telomere-related polymorphisms and the risk of IPF and COPD in a case-control study. MATERIALS AND

methodsA total of 572 patients with IPF (n = 155) or COPD (n = 417), who were derived from our on-going cohort study, and controls (n = 379), who were derived from our previous case-control study, were included in this study.  Telomerase reverse transcriptase (TERT) rs2736100, telomere RNA component (TERC) rs1881984, and oligonucleotide/oligosaccharide-binding fold containing1 (OBFC1) rs11191865 were genotyped with real-time PCR using TaqMan fluorescent probes. Unconditional logistic regression was used to assess the adjusted odds ratios and 95% confidence intervals.

resultsTERT rs2736100 was significantly associated with the risk of IPF; increases in the number of this risk allele increased the risk of IPF (Ptrend = 0.008).  Similarly, TERT rs2736100 was associated with the risk of COPD.  In regard to the combined action of the three loci, increasing numbers of "at-risk" genotypes increased the risk of IPF in a dose-dependent manner (P trend=0.003).

conclusionsTERT rs2736100 was associated with the risks of both IPF and COPD in a Japanese population. A combination of the "at-risk" genotypes might be important to identify the population at risk for IPF more clearly.

Indexed as

Polymorphism, Single NucleotideFemaleHumansIdiopathic Pulmonary FibrosisLung NeoplasmsMalePulmonary Disease, Chronic ObstructiveRegistriesRisk FactorsTelomeraseTelomeraseTERT protein, humanLung cancerOligonucleotide/oligosaccharide-binding fold containing 1Single nucleotide polymorphismTelomerase reverse transcriptaseTelomere RNA component

Identifiers

PMID32212792
PMCPMC7437320
OpenAlexW3013675405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.